Levomepromazine hydrochloride (Wockhardt) Inj 25 mg per ml, 1 ml ampoule: Supply issue resolved

Affected product

Supply of this product has returned to normal levels:  

• Chemical: Levomepromazine hydrochloride
• Presentation: Inj 25 mg per ml, 1 ml ampoule
• Brand: Wockhardt
• Pharmacode: 2501902
• Subsidy: $24.48
• Measure / Qty: per 10

Alternative product

From 1 December 2024, we listed:

• Brand: Nozanin
• Presentation: Inj 25 mg per ml, 1 ml ampoule
• Pharmacode: 2694867
• Quantity: Per 10
• Subsidy: 24.48
• Section 29, Wastage applies.

It is not Medsafe registered. It will need to be prescribed and dispensed in line with section 29 of the Medicines Act.

This section 29 product remains available.

Prescribing and supplying an unapproved medicine

Section 29 of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – such as, a doctor. 

We know supplying a medicine under section 29 is not ideal. In this case, however, this will allow patients to be able to access an appropriate treatment. 

We apologise for any inconvenience this causes. 

Advice for prescribing under section 29 – BPAC website(external link) 

Prescriber and pharmacist requirements for section 29 medicines – Medsafe website (external link)

Medsafe’s section 29 Declaration / Notification Form [DOC](external link)

What patients need to know about unapproved medicines – Healthify website(external link)

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)